MedPath

NeuroCytonix, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

NeuroCytotron in the Treatment of Autism Spectrum Disorder

Not Applicable
Recruiting
Conditions
Autism Spectrum Disorder
First Posted Date
2024-06-27
Last Posted Date
2025-02-06
Lead Sponsor
Neurocytonix, Inc.
Target Recruit Count
100
Registration Number
NCT06477263
Locations
🇲🇽

NeuroCytonix México, San Pedro Garza Garcia, Nuevo León, Mexico

Neurocytotron on Cerebral Palsy

Not Applicable
Completed
Conditions
Cerebral Palsy
First Posted Date
2018-11-16
Last Posted Date
2025-02-13
Lead Sponsor
Neurocytonix, Inc.
Target Recruit Count
53
Registration Number
NCT03743623
Locations
🇲🇽

NeuroCytonix México, Monterrey, San Pedro Garza García, Mexico

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.